Report Detail
Global Bile Duct Cancer Drugs Market Size, Status and Forecast 2019-2025
- RnM3325633 |
- 17 April, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Other
Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unknown, but few factors that cause bile duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as cysts, infection with liver fluke parasites leading to bile duct leading to cancer, and exposure to harmful chemicals or toxins. Major symptoms associated with bile duct cancer include jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and fever. Some drugs used to treat bile duct cancer include 5-fluorouracil (5-fu), gemcitabine, cisplatin, capecitabine and oxaliplatin.
In 2018, the global Bile Duct Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bile Duct Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bile Duct Cancer Drugs development in United States, Europe and China.
The key players covered in this study
Celgene
Mylan
Eli Lilly
Johnson & Johnson
Accord Healthcare
Roche
Teva
AbbVie
Bristol-Myers Squibb
Pfizer
Intercept Pharmaceuticals
Novartis
Sanofi
Kyowa Hakko Kirin
Delcath Systems
Fresenius Kabi
Market segment by Type, the product can be split into
5-Fluorouracil (5-FU)
Gemcitabine
Cisplatin
Capecitabine
Oxaliplatin
Others
Market segment by Application, split into
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bile Duct Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Bile Duct Cancer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bile Duct Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Bile Duct Cancer Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 5-Fluorouracil (5-FU)
- 1.4.3 Gemcitabine
- 1.4.4 Cisplatin
- 1.4.5 Capecitabine
- 1.4.6 Oxaliplatin
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global Bile Duct Cancer Drugs Market Share by Application (2014-2025)
- 1.5.2 Hospitals & Clinic
- 1.5.3 Cancer Treatment Centers
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Bile Duct Cancer Drugs Market Size
- 2.2 Bile Duct Cancer Drugs Growth Trends by Regions
- 2.2.1 Bile Duct Cancer Drugs Market Size by Regions (2014-2025)
- 2.2.2 Bile Duct Cancer Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Bile Duct Cancer Drugs Market Size by Manufacturers
- 3.1.1 Global Bile Duct Cancer Drugs Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Bile Duct Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Bile Duct Cancer Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Bile Duct Cancer Drugs Key Players Head office and Area Served
- 3.3 Key Players Bile Duct Cancer Drugs Product/Solution/Service
- 3.4 Date of Enter into Bile Duct Cancer Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Bile Duct Cancer Drugs Market Size by Type (2014-2019)
- 4.2 Global Bile Duct Cancer Drugs Market Size by Application (2014-2019)
5 United States
- 5.1 United States Bile Duct Cancer Drugs Market Size (2014-2019)
- 5.2 Bile Duct Cancer Drugs Key Players in United States
- 5.3 United States Bile Duct Cancer Drugs Market Size by Type
- 5.4 United States Bile Duct Cancer Drugs Market Size by Application
6 Europe
- 6.1 Europe Bile Duct Cancer Drugs Market Size (2014-2019)
- 6.2 Bile Duct Cancer Drugs Key Players in Europe
- 6.3 Europe Bile Duct Cancer Drugs Market Size by Type
- 6.4 Europe Bile Duct Cancer Drugs Market Size by Application
7 China
- 7.1 China Bile Duct Cancer Drugs Market Size (2014-2019)
- 7.2 Bile Duct Cancer Drugs Key Players in China
- 7.3 China Bile Duct Cancer Drugs Market Size by Type
- 7.4 China Bile Duct Cancer Drugs Market Size by Application
8 Japan
- 8.1 Japan Bile Duct Cancer Drugs Market Size (2014-2019)
- 8.2 Bile Duct Cancer Drugs Key Players in Japan
- 8.3 Japan Bile Duct Cancer Drugs Market Size by Type
- 8.4 Japan Bile Duct Cancer Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Bile Duct Cancer Drugs Market Size (2014-2019)
- 9.2 Bile Duct Cancer Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Bile Duct Cancer Drugs Market Size by Type
- 9.4 Southeast Asia Bile Duct Cancer Drugs Market Size by Application
10 India
- 10.1 India Bile Duct Cancer Drugs Market Size (2014-2019)
- 10.2 Bile Duct Cancer Drugs Key Players in India
- 10.3 India Bile Duct Cancer Drugs Market Size by Type
- 10.4 India Bile Duct Cancer Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Bile Duct Cancer Drugs Market Size (2014-2019)
- 11.2 Bile Duct Cancer Drugs Key Players in Central & South America
- 11.3 Central & South America Bile Duct Cancer Drugs Market Size by Type
- 11.4 Central & South America Bile Duct Cancer Drugs Market Size by Application
12 International Players Profiles
- 12.1 Celgene
- 12.1.1 Celgene Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Bile Duct Cancer Drugs Introduction
- 12.1.4 Celgene Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.1.5 Celgene Recent Development
- 12.2 Mylan
- 12.2.1 Mylan Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Bile Duct Cancer Drugs Introduction
- 12.2.4 Mylan Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.2.5 Mylan Recent Development
- 12.3 Eli Lilly
- 12.3.1 Eli Lilly Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Bile Duct Cancer Drugs Introduction
- 12.3.4 Eli Lilly Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.3.5 Eli Lilly Recent Development
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Bile Duct Cancer Drugs Introduction
- 12.4.4 Johnson & Johnson Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.4.5 Johnson & Johnson Recent Development
- 12.5 Accord Healthcare
- 12.5.1 Accord Healthcare Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Bile Duct Cancer Drugs Introduction
- 12.5.4 Accord Healthcare Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.5.5 Accord Healthcare Recent Development
- 12.6 Roche
- 12.6.1 Roche Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Bile Duct Cancer Drugs Introduction
- 12.6.4 Roche Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.6.5 Roche Recent Development
- 12.7 Teva
- 12.7.1 Teva Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Bile Duct Cancer Drugs Introduction
- 12.7.4 Teva Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.7.5 Teva Recent Development
- 12.8 AbbVie
- 12.8.1 AbbVie Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Bile Duct Cancer Drugs Introduction
- 12.8.4 AbbVie Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.8.5 AbbVie Recent Development
- 12.9 Bristol-Myers Squibb
- 12.9.1 Bristol-Myers Squibb Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Bile Duct Cancer Drugs Introduction
- 12.9.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.9.5 Bristol-Myers Squibb Recent Development
- 12.10 Pfizer
- 12.10.1 Pfizer Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Bile Duct Cancer Drugs Introduction
- 12.10.4 Pfizer Revenue in Bile Duct Cancer Drugs Business (2014-2019)
- 12.10.5 Pfizer Recent Development
- 12.11 Intercept Pharmaceuticals
- 12.12 Novartis
- 12.13 Sanofi
- 12.14 Kyowa Hakko Kirin
- 12.15 Delcath Systems
- 12.16 Fresenius Kabi
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Bile Duct Cancer Drugs Market Size, Status and Forecast 2019-2025. Industry analysis & Market Report on Bile Duct Cancer Drugs Market Size, Status and Forecast 2019-2025 is a syndicated market report, published as Global Bile Duct Cancer Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Bile Duct Cancer Drugs Market Size, Status and Forecast 2019-2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
